Latest Covaxin News & Updates

Bharat Biotech Mulls $500 Million IPO for Covaxin Development

By

New Delhi, March 1 (IANS) The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering that could raise over $500 million, according to sources cited by multiple reports.Discussions are underway including key aspects of the proposed share sale, including size and timing, they said.Bharat Biotech plans Rs 200–250 crore of capital expenditure in FY26 for a large vaccine manufacturing facility being developed under Sapigen Biologix Pvt Ltd in Bhubaneswar, Od…